Bausch Health Companies Inc. Estimated Litigation Liability, Noncurrent
Bausch Health Companies Inc. (BHC) had Estimated Litigation Liability, Noncurrent of $27.00 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LitigationReserveNoncurrent · last filed 2018-08-10
- 2018-03-31: Estimated Litigation Liability, Noncurrent $27.00M.
- 2017-12-31: Estimated Litigation Liability, Noncurrent $20.00M.
- 2017-09-30: Estimated Litigation Liability, Noncurrent $20.00M.
| Period end | Estimated Litigation Liability, Noncurrent |
|---|---|
| 2018-03-31 | $27.00M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $20.00M 8-K · filed 2018-08-10 |
| 2017-09-30 | $20.00M 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |